AGÕæÈ˹ٷ½

Phil Horlock, a director of Blue Bird Corporation (BLBD), reported a sale of company common stock on 08/08/2025. The Form 4 shows a transaction coded as a sale of 30,000 shares at a price shown as $60 per share, leaving the reporting person with 240,766 shares beneficially owned after the transaction. The Form 4 was signed by an attorney-in-fact, Matthew Meziere, on 08/11/2025.

Blue Bird Corp's Form 4 reports that Chief Financial Officer Radulescu Razvan sold 700 shares of common stock on 08/08/2025 at $60.02 per share. After the transaction he beneficially owns 47,503 shares, held directly. The filing lists no derivative transactions and was filed by a single reporting person.

Blue Bird Corporation (BLBD) submitted a Form 144 notice for the proposed sale of 30,000 common shares through UBS Financial Services with an aggregate market value of $1,800,000. The 30,000 shares represent approximately 0.095% of the 31,707,943 shares outstanding. The shares were acquired on 06/08/2016 by RSU vesting. The filing lists prior sales in June 2025 of 8,860 shares (06/10/2025, $363,614), 13,289 shares (06/11/2025, $554,106.93) and 14,875 shares (06/12/2025, $615,527.50), totaling 37,024 shares and $1,533,248.43 in gross proceeds over the past three months. The proposed sale date is approximately 08/08/2025 on NASDAQ. The filer affirms no undisclosed material information in the remarks.

What the filing says: The Form 144 shows a proposed sale of 1,000 common shares of Blue Bird Corporation (BLBD) through Muriel Siebert & Co., with an aggregate market value of $60,000. The shares were acquired by RSU vesting on 07/01/2025 and the proposed sale date is 08/08/2025.

Other disclosed activity: The filing also lists two prior sales by Razvan Radulescu of 10,000 shares each on 07/08/2025 and 08/07/2025 with gross proceeds shown. The notice includes the required signer representation that the seller is not aware of undisclosed material information about the issuer.

Blue Bird Corp. (BLBD) Form 4 filing discloses that Chief Financial Officer Razvan Radulescu sold 10,000 common shares on 08/07/2025 at a weighted-average price of $53.21 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on 08/12/2024, indicating it was pre-scheduled. Following the sale, the CFO directly holds 48,203 BLBD shares. No derivative securities were involved and no additional transactions were reported. The filing was signed by attorney-in-fact Matthew Meziere on 08/08/2025.

Blue Bird (BLBD) reported a strong fiscal Q3-25. Net sales rose 19.4% YoY to $398.0 m, driven by a 14.7% increase in bus unit bookings (2,467 units) and cumulative price hikes that offset tariff-related cost inflation. Gross profit improved 23.9% to $85.9 m; gross margin expanded 80 bp to 21.6%. Operating profit jumped 25.9% to $50.1 m and diluted EPS climbed 31.8% to $1.12 (vs $0.85).

Nine-month performance shows revenue up 7.4% to $1.07 bn and diluted EPS up 13.6% to $2.76. Cash generation remains robust: operating cash flow more than doubled to $111.1 m, lifting cash to $173.1 m. Term-loan principal fell to $92.5 m and the $175 m revolver is undrawn (�$142 m available).

Capital allocation: The company repurchased 1.05 m shares for $39.0 m YTD, reducing shares outstanding to 31.5 m and leaving $11.1 m under the $60 m authorization. Equity income from the Micro Bird JV softened, turning to a $0.4 m loss in Q3. Backlog remains elevated at ~3,900 units, though down from ~4,900 units at FY-24 year-end.

Outlook factors: Management cites continuing, but easing, supply-chain constraints, higher inventory costs from newly imposed tariffs, and uncertainty from the July 2025 tax law (“One Big Beautiful Bill Act�). Nonetheless, ongoing pricing actions, manufacturing efficiencies and solid demand for alternative-power buses underpin margin resilience.